INDV
INDV
NASDAQ · Pharmaceuticals

Indivior Pharmaceuticals Inc

$28.21
+0.06 (+0.21%)
As of Nov 5, 9:55 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +71.9% upside
Low Target $40.68
Average Target $48.50
High Target $71.11
Current Price $28.21
Current
$28.21
Target
$48.50
$40.68 $48.50 avg $71.11
Scenario Analysis
Bear Case
$40.68
44.2%
Low target
Base Case
$48.50
+71.9%
Avg target
Bull Case
$71.11
+152.1%
High target
Risk/Reward
3.4x
Highly favorable
Price in Context
52-Week High
$42.81
-34.1% from high
52-Week Low
$24.74
+14.0% from low
50-Day SMA
$35.18
-19.8% vs SMA
200-Day SMA
$35.68
-20.9% vs SMA
RSI (14)
55.0
Neutral
Target vs 52W High
$48.50
+13.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%